These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8896540)

  • 1. Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children.
    Meurice F; De Bouver JL; Vandevoorde D; Woods S; Bogaerts H
    J Infect Dis; 1996 Nov; 174 Suppl 3():S324-9. PubMed ID: 8896540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children.
    Tan AY; Connett CJ; Connett GJ; Quek SC; Yap HK; Meurice F; Lee BW
    Eur J Pediatr; 1996 Aug; 155(8):706-11. PubMed ID: 8839730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactogenicity and immunogenicity of a live-attenuated refrigerator-stable varicella vaccine (OKA strain) in healthy seronegative subjects age 10 months to 12 years.
    Hadinegoro SR; Hindra IS; Han HH; Gatchalian S; Bock HL
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):991-9. PubMed ID: 19842382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children.
    Lau YL; Vessey SJ; Chan IS; Lee TL; Huang LM; Lee CY; Lin TY; Lee BW; Kwan K; Kasim SM; Chan CY; Kaplan KM; Distefano DJ; Harmon AL; Golie A; Hartzel J; Xu J; Li S; Matthews H; Sadoff JC; Shaw A
    Vaccine; 2002 Jul; 20(23-24):2942-9. PubMed ID: 12126906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
    Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
    Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of high-titer live attenuated varicella vaccine in healthy young children.
    Varis T; Vesikari T
    J Infect Dis; 1996 Nov; 174 Suppl 3():S330-4. PubMed ID: 8896541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.
    Fridman D; Monti A; Bonnet MC; Armoni J; Stamboulian D
    Hum Vaccin; 2011 Oct; 7(10):1066-71. PubMed ID: 21989288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial.
    Hao B; Chen Z; Zeng G; Huang L; Luan C; Xie Z; Chen J; Bao M; Tian X; Xu B; Wang Y; Wu J; Xia S; Yuan L; Huang J
    Clin Microbiol Infect; 2019 Aug; 25(8):1026-1031. PubMed ID: 30616012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
    Ozaki T
    Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
    Ramkissoon A; Coovadia HM; Jugnundan P; Haffejee IE; Meurice F; Vandevoorde D
    S Afr Med J; 1995 Dec; 85(12):1295-8. PubMed ID: 8600589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of live attenuated varicella vaccine in 9-month-old children.
    Kanra G; Ceyhan M; Ozmert E
    Pediatr Int; 2000 Dec; 42(6):674-7. PubMed ID: 11192526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and adverse effects of live attenuated varicella vaccine (Oka-strain) in children with chronic liver disease.
    Nithichaiyo C; Chongsrisawat V; Hutagalung Y; Bock HL; Poovorawa Y
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):101-5. PubMed ID: 11699716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study.
    Faust SN; Le Roy M; Pancharoen C; Weber MAR; Cathie K; Behre U; Bernatoniene J; Snape MD; Helm K; Medina Pech CE; Henry O; Baccarini C; Povey M; Gillard P
    BMC Pediatr; 2019 Feb; 19(1):50. PubMed ID: 30732648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis.
    Kreth HW; Hoeger PH;
    Eur J Pediatr; 2006 Oct; 165(10):677-83. PubMed ID: 16835758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial.
    Huang L; Chen Z; Hu Y; Xie Z; Qiu P; Zhu L; Bao M; Quan Y; Zeng J; Wang Y; Cui X; Yuan L; Xia S; Meng F
    Hum Vaccin Immunother; 2019; 15(4):822-827. PubMed ID: 30481106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for breakthrough varicella in healthy children.
    Lim YJ; Chew FT; Tan AY; Lee BW
    Arch Dis Child; 1998 Dec; 79(6):478-80. PubMed ID: 10210990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.
    Dubey AP; Faridi MMA; Mitra M; Kaur IR; Dabas A; Choudhury J; Mukherjee M; Mishra D
    Hum Vaccin Immunother; 2017 Sep; 13(9):2032-2037. PubMed ID: 28509605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and immunogenicity of lyophilized live attenuated domestic varicella vaccine].
    Chen EF; Jiang ZG; Li Q
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):435-7. PubMed ID: 20084971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial.
    Prymula R; Simko R; Povey M; Kulcsar A
    BMC Pediatr; 2016 Jan; 16():7. PubMed ID: 26762528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.